INS and type 2 diabetes mellitus: A treatment using HucMSC-Exos restored islet structure, reduced the homeostatic model assessment of insulin resistance, and enhanced insulin sensitivity by promoting glucose uptake via GLUT1-4 in T2DM rats (55).